Annual CFF
$74.21 M
+$91.08 M+539.91%
31 December 2023
Summary:
Verrica Pharmaceuticals annual cash flow from financing activities is currently $74.21 million, with the most recent change of +$91.08 million (+539.91%) on 31 December 2023. During the last 3 years, it has risen by +$38.98 million (+110.64%). VRCA annual CFF is now -25.32% below its all-time high of $99.38 million, reached on 31 December 2018.VRCA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$397.00 K
+$243.00 K+37.97%
30 September 2024
Summary:
Verrica Pharmaceuticals quarterly cash flow from financing activities is currently -$397.00 thousand, with the most recent change of +$243.00 thousand (+37.97%) on 30 September 2024. Over the past year, it has dropped by -$44.44 million (-100.90%). VRCA quarterly CFF is now -100.50% below its all-time high of $79.44 million, reached on 30 June 2018.VRCA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$1.73 M
-$44.44 M-104.04%
30 September 2024
Summary:
Verrica Pharmaceuticals TTM cash flow from financing activities is currently -$1.73 million, with the most recent change of -$44.44 million (-104.04%) on 30 September 2024. Over the past year, it has dropped by -$75.97 million (-102.32%). VRCA TTM CFF is now -101.55% below its all-time high of $111.51 million, reached on 30 June 2018.VRCA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRCA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +539.9% | -100.9% | -102.3% |
| 3 y3 years | +110.6% | -1023.3% | -105.1% |
| 5 y5 years | -25.3% | -10000.0% | -856.6% |
VRCA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +539.9% | -100.9% | +97.6% | -102.3% | +89.8% |
| 5 y | 5 years | -25.3% | +539.9% | -100.9% | +97.6% | -102.3% | +89.8% |
| alltime | all time | -25.3% | +539.9% | -100.5% | +97.6% | -101.5% | +89.8% |
Verrica Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$397.00 K(-38.0%) | -$1.73 M(-104.0%) |
| June 2024 | - | -$640.00 K(-3.2%) | $42.72 M(-1.3%) |
| Mar 2024 | - | -$661.00 K(+2348.1%) | $43.27 M(-41.7%) |
| Dec 2023 | $74.21 M(-539.9%) | -$27.00 K(-100.1%) | $74.21 M(-0.0%) |
| Sept 2023 | - | $44.04 M(<-9900.0%) | $74.24 M(+456.3%) |
| June 2023 | - | -$84.00 K(-100.3%) | $13.35 M(-0.6%) |
| Mar 2023 | - | $30.28 M(>+9900.0%) | $13.43 M(-179.6%) |
| Dec 2022 | -$16.87 M(-150.1%) | $0.00(-100.0%) | -$16.87 M(-0.0%) |
| Sept 2022 | - | -$16.85 M(>+9900.0%) | -$16.87 M(<-9900.0%) |
| June 2022 | - | -$1000.00(-94.4%) | $21.00 K(-92.0%) |
| Mar 2022 | - | -$18.00 K(+500.0%) | $263.00 K(-99.2%) |
| Dec 2021 | $33.65 M(-4.5%) | -$3000.00(-107.0%) | $33.65 M(-1.3%) |
| Sept 2021 | - | $43.00 K(-82.2%) | $34.09 M(+0.1%) |
| June 2021 | - | $241.00 K(-99.3%) | $34.05 M(+1.0%) |
| Mar 2021 | - | $33.37 M(+7397.8%) | $33.72 M(-4.3%) |
| Dec 2020 | $35.23 M | $445.00 K(>+9900.0%) | $35.23 M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $0.00(-100.0%) | $34.99 M(-0.0%) |
| June 2020 | - | -$90.00 K(-100.3%) | $34.99 M(-0.9%) |
| Mar 2020 | - | $34.88 M(>+9900.0%) | $35.30 M(+8244.4%) |
| Dec 2019 | $423.00 K(-99.6%) | $204.00 K(+5000.0%) | $423.00 K(+85.5%) |
| Sept 2019 | - | $4000.00(-98.1%) | $228.00 K(-127.1%) |
| June 2019 | - | $212.00 K(+6966.7%) | -$840.00 K(-101.1%) |
| Mar 2019 | - | $3000.00(-66.7%) | $78.39 M(-21.1%) |
| Dec 2018 | $99.38 M(+681.3%) | $9000.00(-100.8%) | $99.38 M(-9.2%) |
| Sept 2018 | - | -$1.06 M(-101.3%) | $109.48 M(-1.8%) |
| June 2018 | - | $79.44 M(+278.4%) | $111.51 M(+235.6%) |
| Mar 2018 | - | $20.99 M(+107.6%) | $33.23 M(+161.3%) |
| Dec 2017 | $12.72 M(+2533.3%) | $10.11 M(+948.1%) | $12.72 M(+388.3%) |
| Sept 2017 | - | $965.00 K(-16.7%) | $2.60 M(+58.8%) |
| June 2017 | - | $1.16 M(+140.2%) | $1.64 M(+240.2%) |
| Mar 2017 | - | $482.00 K | $482.00 K |
| Dec 2016 | $483.00 K | - | - |
FAQ
- What is Verrica Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual CFF year-on-year change?
- What is Verrica Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly CFF year-on-year change?
- What is Verrica Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals TTM CFF year-on-year change?
What is Verrica Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of VRCA is $74.21 M
What is the all time high annual CFF for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual cash flow from financing activities is $99.38 M
What is Verrica Pharmaceuticals annual CFF year-on-year change?
Over the past year, VRCA annual cash flow from financing activities has changed by +$91.08 M (+539.91%)
What is Verrica Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of VRCA is -$397.00 K
What is the all time high quarterly CFF for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly cash flow from financing activities is $79.44 M
What is Verrica Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, VRCA quarterly cash flow from financing activities has changed by -$44.44 M (-100.90%)
What is Verrica Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of VRCA is -$1.73 M
What is the all time high TTM CFF for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high TTM cash flow from financing activities is $111.51 M
What is Verrica Pharmaceuticals TTM CFF year-on-year change?
Over the past year, VRCA TTM cash flow from financing activities has changed by -$75.97 M (-102.32%)